FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fed Chair Powell's comments on December rate cut uncertainty send markets into a mixed reaction, with Treasury yields rising and small caps falling.
Trump orders immediate restart of U.S. nuclear testing, raising international concern.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Fed Chair Powell's comments on December rate cut uncertainty send markets into a mixed reaction, with Treasury yields rising and small caps falling.
Trump orders immediate restart of U.S. nuclear testing, raising international concern.